Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence

Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a disorder which can adopt three clinical expressions: two classical forms - salt-wasting (SW), with residual enzymatic activity (EA) ≤1% and simple virilizing (SV), with EA 1-2%- and a mild late onset or nonclassical (NC) form...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autor principal: Minutolo, Carolina
Publicado: 2007
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v67_n3_p253_Pasqualini
http://hdl.handle.net/20.500.12110/paper_00257680_v67_n3_p253_Pasqualini
Aporte de:
id paper:paper_00257680_v67_n3_p253_Pasqualini
record_format dspace
spelling paper:paper_00257680_v67_n3_p253_Pasqualini2023-06-08T14:53:37Z Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence Minutolo, Carolina Congenital adrenal hyperplasia Congenital adrenal hyperplasia clinical characteristics Congenital adrenal hyperplasia molecular genetics corticotropin dexamethasone fludrocortisone hydrocortisone hydroxyprogesterone methylprednisolone steroid 21 monooxygenase adolescent adult allele article body height bone mass child clinical article clinical feature congenital adrenal hyperplasia controlled study enzyme activity family study female follow up gene expression gene mutation genetic code genetic counseling genetic screening genotype heterozygote human low drug dose male mutational analysis newborn prediction puberty reference value sibling steroid 21 monooxygenase deficiency symptom Adolescent Adrenal Hyperplasia, Congenital Alleles Child Child, Preschool Female Follow-Up Studies Gene Conversion Genotype Humans Infant Infant, Newborn Male Mutation Phenotype Point Mutation Steroid 21-Hydroxylase Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a disorder which can adopt three clinical expressions: two classical forms - salt-wasting (SW), with residual enzymatic activity (EA) ≤1% and simple virilizing (SV), with EA 1-2%- and a mild late onset or nonclassical (NC) form, with EA 10-60%. Our objective is to describe clinical characteristics, growth, and bone mass in a group of patients affected by 21-hydroxylase deficiency. Besides, molecular genetics studies were performed in patients, and also when available in their parents and siblings. Nine patients with neonatal diagnosis and 8 with pre or postpubertal diagnosis were studied. Analyses of 10-point mutations in the CYP21A2 gene were performed. We found that all the patients with the classical expression, except one with a de novo mutation R356W in one allele, were fully genotyped with predictive <2% EA mutations. Signs of hyperandrogenism were present in 5/6 NC patients; one was diagnosed by searching for mutations in asymptomatic siblings. All the NC patients were compound heterozygotes carrying V281L mutation in one allele and a predictive low EA in the other, except for one not yet determined. In patients with neonatal diagnosis, mean height was low at one year of age, though it showed a significant increase before the onset of puberty. We conclude that neonatal diagnosis of classical CAH allows an adequate follow up enhancing growth. Molecular analyses of all members of an affected family may disclose asymptomatic patients. The presence of de novo mutations, as well as, the presence of mutations with low predicted EA in NC patients reinforces the importance of genotyping for appropriate genetic counseling. In fully genotyped NC patients, the lowest value of ACTH-stimulated 17OHP was 14 ng/ml. Lower cut-off values might overestimate the diagnosis of the NC form. Fil:Minutolo, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2007 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v67_n3_p253_Pasqualini http://hdl.handle.net/20.500.12110/paper_00257680_v67_n3_p253_Pasqualini
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Congenital adrenal hyperplasia
Congenital adrenal hyperplasia clinical characteristics
Congenital adrenal hyperplasia molecular genetics
corticotropin
dexamethasone
fludrocortisone
hydrocortisone
hydroxyprogesterone
methylprednisolone
steroid 21 monooxygenase
adolescent
adult
allele
article
body height
bone mass
child
clinical article
clinical feature
congenital adrenal hyperplasia
controlled study
enzyme activity
family study
female
follow up
gene expression
gene mutation
genetic code
genetic counseling
genetic screening
genotype
heterozygote
human
low drug dose
male
mutational analysis
newborn
prediction
puberty
reference value
sibling
steroid 21 monooxygenase deficiency
symptom
Adolescent
Adrenal Hyperplasia, Congenital
Alleles
Child
Child, Preschool
Female
Follow-Up Studies
Gene Conversion
Genotype
Humans
Infant
Infant, Newborn
Male
Mutation
Phenotype
Point Mutation
Steroid 21-Hydroxylase
spellingShingle Congenital adrenal hyperplasia
Congenital adrenal hyperplasia clinical characteristics
Congenital adrenal hyperplasia molecular genetics
corticotropin
dexamethasone
fludrocortisone
hydrocortisone
hydroxyprogesterone
methylprednisolone
steroid 21 monooxygenase
adolescent
adult
allele
article
body height
bone mass
child
clinical article
clinical feature
congenital adrenal hyperplasia
controlled study
enzyme activity
family study
female
follow up
gene expression
gene mutation
genetic code
genetic counseling
genetic screening
genotype
heterozygote
human
low drug dose
male
mutational analysis
newborn
prediction
puberty
reference value
sibling
steroid 21 monooxygenase deficiency
symptom
Adolescent
Adrenal Hyperplasia, Congenital
Alleles
Child
Child, Preschool
Female
Follow-Up Studies
Gene Conversion
Genotype
Humans
Infant
Infant, Newborn
Male
Mutation
Phenotype
Point Mutation
Steroid 21-Hydroxylase
Minutolo, Carolina
Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence
topic_facet Congenital adrenal hyperplasia
Congenital adrenal hyperplasia clinical characteristics
Congenital adrenal hyperplasia molecular genetics
corticotropin
dexamethasone
fludrocortisone
hydrocortisone
hydroxyprogesterone
methylprednisolone
steroid 21 monooxygenase
adolescent
adult
allele
article
body height
bone mass
child
clinical article
clinical feature
congenital adrenal hyperplasia
controlled study
enzyme activity
family study
female
follow up
gene expression
gene mutation
genetic code
genetic counseling
genetic screening
genotype
heterozygote
human
low drug dose
male
mutational analysis
newborn
prediction
puberty
reference value
sibling
steroid 21 monooxygenase deficiency
symptom
Adolescent
Adrenal Hyperplasia, Congenital
Alleles
Child
Child, Preschool
Female
Follow-Up Studies
Gene Conversion
Genotype
Humans
Infant
Infant, Newborn
Male
Mutation
Phenotype
Point Mutation
Steroid 21-Hydroxylase
description Congenital adrenal hyperplasia (CAH) due to 21-hydroxylase deficiency is a disorder which can adopt three clinical expressions: two classical forms - salt-wasting (SW), with residual enzymatic activity (EA) ≤1% and simple virilizing (SV), with EA 1-2%- and a mild late onset or nonclassical (NC) form, with EA 10-60%. Our objective is to describe clinical characteristics, growth, and bone mass in a group of patients affected by 21-hydroxylase deficiency. Besides, molecular genetics studies were performed in patients, and also when available in their parents and siblings. Nine patients with neonatal diagnosis and 8 with pre or postpubertal diagnosis were studied. Analyses of 10-point mutations in the CYP21A2 gene were performed. We found that all the patients with the classical expression, except one with a de novo mutation R356W in one allele, were fully genotyped with predictive <2% EA mutations. Signs of hyperandrogenism were present in 5/6 NC patients; one was diagnosed by searching for mutations in asymptomatic siblings. All the NC patients were compound heterozygotes carrying V281L mutation in one allele and a predictive low EA in the other, except for one not yet determined. In patients with neonatal diagnosis, mean height was low at one year of age, though it showed a significant increase before the onset of puberty. We conclude that neonatal diagnosis of classical CAH allows an adequate follow up enhancing growth. Molecular analyses of all members of an affected family may disclose asymptomatic patients. The presence of de novo mutations, as well as, the presence of mutations with low predicted EA in NC patients reinforces the importance of genotyping for appropriate genetic counseling. In fully genotyped NC patients, the lowest value of ACTH-stimulated 17OHP was 14 ng/ml. Lower cut-off values might overestimate the diagnosis of the NC form.
author Minutolo, Carolina
author_facet Minutolo, Carolina
author_sort Minutolo, Carolina
title Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence
title_short Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence
title_full Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence
title_fullStr Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence
title_full_unstemmed Congenital adrenal hyperplasia. Clinical characteristics and genotype in newborn, childhood and adolescence
title_sort congenital adrenal hyperplasia. clinical characteristics and genotype in newborn, childhood and adolescence
publishDate 2007
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00257680_v67_n3_p253_Pasqualini
http://hdl.handle.net/20.500.12110/paper_00257680_v67_n3_p253_Pasqualini
work_keys_str_mv AT minutolocarolina congenitaladrenalhyperplasiaclinicalcharacteristicsandgenotypeinnewbornchildhoodandadolescence
_version_ 1768544120910905344